John Hamill
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John Hamill
John Hamill is recorded as CFO at Aprea Therapeutics, Inc. (APRE). Aprea Therapeutics, Inc. reported in an 8-K filed January 30, 2023 that John Hamill was appointed Senior Vice President, Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer, effective January 30, 2023.
“Effective January 30, 2023 (the "Transition Date"), John Hamill became Senior Vice President, Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer of Aprea Therapeutics, Inc. (the "Company").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-30–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Aprea Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Oren Gilad CEO
- Richard Peters, M.D., Ph.D. Chairman, Board Member
- Scott M. Coiante CFO
- Greg Korbel COO
- Bernd Seizinger Board Member
- Fouad Namouni, M.D. Board Member
- Gabriela Gruia Board Member
- Gabriela Gruia, M.D. Board Member
- Jean-Pierre Bizzari Board Member
- Marc Duey Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.